Table 2. Validation of UC Santa Cruz Multiplex SARS-CoV-2 assay by a commercial lab using true positive and true negative clinical samples.

Samples Tested Individually	Comparator Method Result
Candidate Test Result	Positive	Negative
Positive	30	0
Negative	0	30

(samples collected on symptomatic patients).

Performance of the UCSC Multiplex SARS-CoV-2 Assay against the Pangea comparator: Positive Percent Agreement: 30/30 = 100% (95%CI: 90%-100%), Negative Percent Agreement: 30/30 = 100% (95%CI: 90%-100%).